Acne in Patients with Skin of Color: Medical & Procedural Treatment Strategies
The 2023 Skin of Color Update in New York City featured a comprehensive discussion on the evolving landscape of treating acne, with a particular focus on medical and procedural approaches. Attendees had the unique opportunity to hear Dr. Valerie Callendar, professor of dermatology at Howard University College of Medicine in Washington, DC, and Dr. Andrew Alexis, Professor of Clinical Dermatology …
The 2023 Skin of Color Update in New York City featured a comprehensive discussion on the evolving landscape of treating acne, with a particular focus on medical and procedural approaches. Attendees had the unique opportunity to hear Dr. Valerie Callendar, professor of dermatology at Howard University College of Medicine in Washington, DC, and Dr. Andrew Alexis, Professor of Clinical Dermatology … Continue reading "Acne in Patients with Skin of Color: Medical & Procedural Treatment Strategies"
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Pearl E. Grimes, symposium chair and clinical professor of dermatology at the University of California, Los Angeles. Hear the “why” behind the Pigmentary Disorders Exchange Symposium from its founding chair. Learn what Dr. Grimes believes is a common myth about pigmentary disorders. Plus hear what m … 
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Jill S. Waibel, subsection chief of dermatology at Baptist Hospital of Miami, medical director of the Miami Cancer Institute’s Multispecialty Skin Cancer Clinic, and assistant voluntary professor at the University of Miami Miller School of Medicine. Learn about the emerging field of laser-assisted dru … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Dr. Alexis points out that acne is the most common dermatologic condition for which patients with skin of color seek a dermatologist’s care. Hear why it’s impor … 
Azelaic acid is a topical therapeutic agent which is FDA approved to treat papules and pustules of mild to moderate rosacea and mild to moderate acne vulgaris. It was first approved by the FDA in 1995 and since its approval, has been used for many off-label conditions including disorders of hyperpigmentation. Its utility in various conditions can be attributed to its anti-microbial, anti-inflamm … 